Literature DB >> 18376394

A sensitive direct human telomerase activity assay.

Scott B Cohen1, Roger R Reddel.   

Abstract

Expression of telomerase, the specialized reverse transcriptase that adds 5'-TTAGGG-3' repeats to the ends of human chromosomes, is upregulated in > or =85% of human cancers and tumor cell lines. We describe a direct primer-extension activity assay for human telomerase that displays sensitivity to approximately 10(6) telomerase-positive cells, making the method suitable for use with standard cell culture-based research (Fig. 1). Telomerase is first immunoaffinity purified from cell lysate using an antibody to telomerase and captured using protein G-agarose beads (Steps 14-17). Then telomerase is dissociated from the beads using excess peptide antigen (Step 19). A second affinity purification exploits the stable binding interaction between human telomerase and the telomeric DNA substrate 5'-(TTAGGG)3-3' (dissociation half-life > or = 10 h at 23 degrees C). Modifying neutravidin beads with 5'-biotin-CTAGACCTGTCATCA(TTAGGG)3-3' (Step 5) generates an affinity reagent that captures >90% of immunopurified telomerase (Step 22), providing highly enriched telomerase bound to its DNA substrate in a volume of 20 mul of beads. Addition of assay buffer results in extension of the bead-immobilized DNA substrate (Step 24). Telomerase extension products are released by heating in denaturing formamide buffer to disrupt the avidin-biotin interaction, and then separated and visualized by standard techniques.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18376394     DOI: 10.1038/nmeth.f.209

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  35 in total

1.  Telomerase activity in pleural malignant mesotheliomas.

Authors:  Amy Y M Au; Torben Hackl; Thomas R Yeager; Scott B Cohen; Harvey I Pass; Curtis C Harris; Roger R Reddel
Journal:  Lung Cancer       Date:  2011-01-31       Impact factor: 5.705

2.  Telomerase recruitment requires both TCAB1 and Cajal bodies independently.

Authors:  J Lewis Stern; Katherine G Zyner; Hilda A Pickett; Scott B Cohen; Tracy M Bryan
Journal:  Mol Cell Biol       Date:  2012-04-30       Impact factor: 4.272

3.  ATM and ATR Signaling Regulate the Recruitment of Human Telomerase to Telomeres.

Authors:  Adrian S Tong; J Lewis Stern; Agnel Sfeir; Melissa Kartawinata; Titia de Lange; Xu-Dong Zhu; Tracy M Bryan
Journal:  Cell Rep       Date:  2015-11-12       Impact factor: 9.423

4.  NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination.

Authors:  Dimitri Conomos; Roger R Reddel; Hilda A Pickett
Journal:  Nat Struct Mol Biol       Date:  2014-08-24       Impact factor: 15.369

5.  Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.

Authors:  Sumit Borah; Linghe Xi; Arthur J Zaug; Natasha M Powell; Garrett M Dancik; Scott B Cohen; James C Costello; Dan Theodorescu; Thomas R Cech
Journal:  Science       Date:  2015-02-05       Impact factor: 47.728

6.  Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.

Authors:  Hunter Hoffman; Cory Rice; Emmanuel Skordalakes
Journal:  J Biol Chem       Date:  2017-02-01       Impact factor: 5.157

7.  Spontaneous occurrence of telomeric DNA damage response in the absence of chromosome fusions.

Authors:  Anthony J Cesare; Zeenia Kaul; Scott B Cohen; Christine E Napier; Hilda A Pickett; Axel A Neumann; Roger R Reddel
Journal:  Nat Struct Mol Biol       Date:  2009-11-22       Impact factor: 15.369

8.  A mechanism for the extension and unfolding of parallel telomeric G-quadruplexes by human telomerase at single-molecule resolution.

Authors:  Bishnu P Paudel; Aaron Lavel Moye; Hala Abou Assi; Roberto El-Khoury; Scott B Cohen; Jessica K Holien; Monica L Birrento; Siritron Samosorn; Kamthorn Intharapichai; Christopher G Tomlinson; Marie-Paule Teulade-Fichou; Carlos González; Jennifer L Beck; Masad J Damha; Antoine M van Oijen; Tracy M Bryan
Journal:  Elife       Date:  2020-07-29       Impact factor: 8.140

9.  Targeted Covalent Inhibition of Telomerase.

Authors:  Rick C Betori; Yue Liu; Rama K Mishra; Scott B Cohen; Stephen J Kron; Karl A Scheidt
Journal:  ACS Chem Biol       Date:  2020-02-24       Impact factor: 5.100

10.  Catalysis-dependent inactivation of human telomerase and its reactivation by intracellular telomerase-activating factors (iTAFs).

Authors:  Mohammed E Sayed; Ao Cheng; Gaya P Yadav; Andrew T Ludlow; Jerry W Shay; Woodring E Wright; Qiu-Xing Jiang
Journal:  J Biol Chem       Date:  2019-06-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.